Cargando…
Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines
Oxaliplatin displays a wide spectrum of antitumor activities and is widely used in the treatment of metastatic colorectal cancer (CRC). However, tumor responses to this agent are variable, and the underlying mechanisms are poorly understood. In the present study, oxaliplatin was found to strongly in...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016804/ https://www.ncbi.nlm.nih.gov/pubmed/27609465 http://dx.doi.org/10.1038/srep33078 |